Gender Differences in VLDL1 and VLDL2 Triglyceride Kinetics and Fatty Acid Kinetics in Obese Postmenopausal Women and Obese Men

University of Cambridge, Cambridge, England, United Kingdom
The Journal of Clinical Endocrinology and Metabolism (Impact Factor: 6.31). 04/2012; 97(7):2475-81. DOI: 10.1210/jc.2011-3248
Source: PubMed

ABSTRACT High plasma triglycerides (TG) have been shown to be independent and better predictors of cardiovascular disease than low-density lipoprotein (LDL) cholesterol in women. This may be due to gender differences in very-low-density lipoprotein 1 (VLDL(1))- and VLDL(2)-TG and fatty acid kinetics.
Our objective was to investigate whether there are differences in VLDL(1)- and VLDL(2)-TG and fatty acid kinetics in obese men and postmenopausal women, a high risk group for cardiovascular disease.
Stable isotopes techniques were used to measure fasting palmitate rate of appearance, metabolic clearance rate, oxidation rate, and nonoxidative disposal rate, VLDL(1)-TG and VLDL(2)-TG fractional catabolic rate (FCR) and production rate (PR). Whole-body fat distribution was measured by magnetic resonance imaging.
Participants included 10 postmenopausal obese women and eight obese men matched for age, body mass index, and fasting plasma TG.
The women had lower visceral fat and higher sc fat than the men (P < 0.001 and P < 0.002). Palmitate rate of appearance, metabolic clearance rate, nonoxidative disposal rate, and oxidation rate corrected for resting energy expenditure were greater in the women than the men (all P < 0.03). VLDL(2)-TG PR corrected for fat-free mass was higher in the women (P < 0.001). VLDL(2)-TG and VLDL(2)-cholesterol pools were higher in the women (P < 0.001 and P < 0.008). VLDL(1)-TG FCR and PR and VLDL(2)-TG FCR were not different between genders.
Fatty acid and VLDL(2)-TG flux is higher in postmenopausal obese women than in obese men matched for fasting plasma TG levels.

Download full-text


Available from: Jimmy David Bell, Mar 06, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The study aimed to 1] develop a method which completely separated hepatic (VLDL1, VLDL2) and intestinal (chylomicron, CM) lipoproteins and 2] use the method to measure triacylglycerol (TAG) kinetics in these lipoproteins in the fed and fasting state in healthy subjects using intravenous (2)H5-glycerol as the tracer. An immunoaffinity method which completely separated hepatic and intestinal particles using sequential binding to three antibodies to apolipoprotein B100 (apoB100) was established and validated. Six healthy volunteers were studied in a fasted and continuous feeding study (study 1). Five additional healthy volunteers were studied in a continuous feeding study which included an oral (13)C3-glycerol tripalmitin tracer (study 2). In both studies an intravenous bolus of (2)H5-glycerol was administered to label TAG in hepatic and intestinal lipoproteins. In both feeding studies there was sufficient incorporation of the glycerol tracer into the exogenous lipoproteins to enable isotopic enrichment to be measured. In study 2 the oral tracer enrichment in VLDL1 was <5% of CM enrichment, 150 minutes after tracer administration demonstrating negligible contamination of VLDL1 with apoB48. Western blotting showed no detectable apoB100 in CMs. VLDL1 and VLDL2 TAG fractional catabolic rate (FCR) did not differ between feeding and fasting (study 1). There was no difference between CM and VLDL1 TAG FCR in both fed studies. In fed study 2, 47% of the total TAG production rate (CM+VLDL1) was from CM. This methodology may be a useful tool for understanding the abnormalities in postprandial TAG kinetics in metabolic syndrome and type 2 diabetes.
    AJP Endocrinology and Metabolism 04/2013; 305(8). DOI:10.1152/ajpendo.00105.2013 · 4.09 Impact Factor